Echo Therapeutics (ECTE) Reports Q3 Loss of $0.16/Share
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Price: $0.00 --0%
Financial Fact:
Derivative warrant liability gain (loss): 3.68M
Today's EPS Names:
VFS, AYI, PKE, More
Financial Fact:
Derivative warrant liability gain (loss): 3.68M
Today's EPS Names:
VFS, AYI, PKE, More
Join SI Premium – FREE
Echo Therapeutics (NASDAQ: ECTE) reported Q3 EPS of ($0.16), versus ($0.21) reported last year.
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron Technology (MU) Tops Q4 EPS by $2.26, Offers Guidance
- FreeCast reports 13% revenue rise and 42% ad revenue growth in fiscal 2026
- Synopsys sets fiscal 2027 revenue target of $11.15B at investor day
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
